PRESENTATION
MYCOTREAT 500 (Mycophenolate Mofetil 500 mg Tablets) is available as 1 x 6 x 10 Tablets/Box.
DESCRIPTION
Mycophenolate Mofetil is a synthetic analog of mycophenolic acid that is produced by several Penicillium species. It is an antiproliferative immunosuppressant and is used in combination with calcineurin inhibitors and other corticosteroids for the prophylaxis of acute rejection in renal, hepatic or cardiac transplants. Mycophenolate Mofetil is proven as a safer non-nephrotoxic and efficacious immunosuppressant to prevent graft rejections, thus improving overall post-transplant patient survival.
INDICATIONS AND USAGE
MYCOTREAT (Mycophenolate Mofetil) is an immunosuppressant drug that is used in combination with calcineurin inhibitors and other corticosteroids for the prophylaxis of acute rejection in renal, hepatic, or cardiac transplant. It can also be lupus nephritis, rheumatoid arthritis and refractory rejection.
DOSAGE
Adults: A dose of 1gm twice a day orally is recommended for renal transplant recipients.
Paediatric (3 months to 18 years): Patients having a body surface area of 1.25-1.5 m² dose can be 750 mg twice a day and the ones having a body surface area of more than 1.5 m² dose may be 1 gm twice daily.
CONTRAINDICATIONS
It cannot be given to patients with hypersensitivity to polysorbate 80, MPA, mycophenolate mofetil or its contents.
© Copyright 2023 Genix Lifescience Pvt Ltd. All Rights Reserved. | Managed & Developed By Webkart Digital Pvt. Ltd.